Delirium tremens is recognized as a potentially fatal and debilitating complication of ethanol withdrawal. Research thus far has primarily focused on the prevention of delirium tremens.
Rouse BA. Substance Abuse and Mental Health Statistics Source Book. Rockville, MD: Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 1998.
2.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.Washington, DC: American Psychiatric Association; 2000.
3.
Palmstierna T.A model of predicting alcohol withdrawal delirium. Psychiatr Serv. 2001;52:820-823.
4.
Schuckit MA, Barunwald E:Alcohol and alcoholism. In: Braunwald E, Fauci AS, Isselbacher KJ, et al, eds. Harrison’s Principle of Internal Medicine. 15th ed.New York, NY: McGraw-Hill; 2001-2004:387, 1036.
5.
Myrick H, Anton RF:Treatment of alcohol withdrawal. Alcohol Health Res World. 1998;22:38-43.
6.
Amos JJ, Crowe R, Doebbling CC, et al.Treatment of Alcohol Withdrawal. University of Iowa, 1992-2004.
7.
Erwin WE, Williams DB, Speir WA:Delirium tremens. South Med J. 1998;91:425-432.
8.
Danenberg HD, Nahir M, Hasin Y:Acute myocardial infarction due to delirium tremens. Cardiology. 1999;92:144.
9.
Feuerlein W, Reiser E.Parameters affecting the course and results of delirium tremens treatment. Acta Psychiatr Scand. 1986;329:120-123.
10.
Fleming M, Mihic SJ, Harris RA. Ethanol. In: Hardman JG, Limbard LE, Gilman AG, eds. The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 2001:429-445.
11.
Grobin AC, Matthews DB, Devaud LL, Morrow AL. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology. 1998; 139:2-19.
12.
Kuriyama K, Ueha T.Functional alterations in cerebral GABAA receptor complex associated with formation of alcohol dependence: analysis using GABA-dependent 36Cl- influx into neuronal membrane vesicles. Alcohol Alcohol. 1992;27:335-343.
13.
Mihic SJ, Ye Q, Marilee JM, et al.Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature. 1997;389:385-389.
14.
Krystal JH, Petrakis IL, Krupitsky E, et al.NMDA receptor antagonism and the ethanol intoxication signal. Ann N Y Acad Sci. 2003;1003:176-184.
15.
Tsai G, Coyle JT. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med. 1998;49:173-184.
16.
Alcohol Withdrawal Syndrome Guidelines. Orlando, Fla: Department of Surgical Education, Orlando Medical Center; 2003.
17.
Clancy G.Alcohol related emergencies. In Emergency Psychiatry Handbook: Major Emergencies—Naval Hospital. 1997-2004.
18.
Fuller RK, Gordis E.Refining the treatment of alcohol withdrawal. JAMA. 1994; 272:557-558.
19.
Hersh D, Kranzler HR, Meyer RE. Persistent delirium following cessation of heavy alcohol consumption: diagnostic and treatment implications. Am J Psychiatry. 1997;54:846-851.
20.
Burnham TH, Wickersham RM, Novak KK, eds. Drug Facts and Comparisons. St. Louis, Mo: Wolters Kluwer; 2002.
21.
McMicken DB. Alcohol withdrawal syndromes. Emerg Med Clin North Am. 1990;8:805-819.
22.
Charney DS, Mihic SJ, Harris RA. Hypnotics and sedatives. In: Hardman JG, Limbard LE, Gilman AG, eds: The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill, 2001:399-427.
23.
Nutt D, Adinoff B, Linnoila M.Benzodiazepines in the treatment of alcoholism. Recent Dev Alcohol. 1989;8:283-313.
24.
Nolop KB, Natow A.Unprecedented sedative requirements during delirium tremens. Crit Care Med. 1985;13:246-249.
25.
Iwata N, Cowley DS, Radel M, et al.Relationship between a GABAAα6 Pro385Ser substitution and benzodiazepine sensitivity. Am J Psychiatry. 1999;156:1447-1449.
26.
Daeppen JB, Gache P, Landry U.Symptom triggered vs. fixed schedule doses of benzodiazepines for alcohol withdrawal. Arch Intern Med. 2002;162:1117-1121.
27.
Baldessarini RJ, Tarazi FI. Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbard LE, Gilman AG, eds: The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill, 2001:485-520.
28.
Gleason OC. Delirium. Am Fam Physician. 2003;67:1027-1034.
29.
Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry. 1999;156(5 Suppl):1-20.
30.
Mayo-Smith MF, Cushman PJ, Hill AJ, et al.Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278:145-151.
31.
McCowan C, Marik P.Refractory delirium tremens treated with propofol: a case series. Crit Care Med. 2000;28:1781-1784.
32.
Evers AS, Crowder CM. General anesthetics. In: Hardman JG, Limbard LE, Gilman AG: The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 2001:337-365.
33.
Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Eng J Med. 2003;348:1786-1795.
34.
Sullivan JT, Sykora K, Schneiderman J, et al.Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353-1357.
35.
Valente JF, Anderson GL, Branson RD, et al.Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med. 1994;22:710-712.
